METROGEL® (metronidazole) Gel, 1% is the only branded prescription rosacea treatment that comes in a convenient pump that provides a measured dose for consistent delivery. Roll over the points of interest below to learn more about what makes the METROGEL 1% Pump unique.
It works. METROGEL 1% is proven to reduce the bumps and blemishes of rosacea.
The preferred choice. In a consumer packaging survey among rosacea sufferers, the majority of people preferred a pump to a tube.
Easy to use. The Pump is easy to fit into your skin care routine and may have less mess than a tube.
No parts to lose. There are no removable parts on the Pump, so you don't have to worry about losing the cap behind the sink or down the drain.
Ready for its close-up. In a survey, most people agreed that a pump was more attractive than a tube and more suitable for countertop display.
Use just once daily. METROGEL 1% is the only branded prescription rosacea treatment with once-daily dosing in a pump delivery system.
Still #1. METROGEL has been the #1 prescribed topical medication for rosacea for the past decade.
No guesswork. The Pump offers a measured dose for consistent delivery, with no need to guess how much to squeeze out of a tube.
IMPORTANT SAFETY INFORMATION
Indication: METROGEL® 1% is indicated
for the topical treatment of the inflammatory lesions of rosacea. Adverse Events:
In controlled clinical studies, the most commonly reported adverse events (>2%)
in patients treated with METROGEL 1% were nasopharyngitis, upper respiratory tract
infection, and headache. Other adverse experiences reported when using topical metronidazole
include skin irritation, transient redness, metallic taste, tingling or numbness
of the extremities and nausea. Warnings/Precautions: METROGEL 1%
should not be used by patients who are allergic to metronidazole or any ingredient
in METROGEL 1%. Avoid contact of METROGEL 1% with the eyes as it may cause tearing.
METROGEL 1% should be used with caution in patients with evidence of, or a history
of, blood dyscrasia, and with patients taking blood thinning agents as they may
experience prolonged prothrombin times. METROGEL 1% treatment should be discontinued
if numbness or paresthesia of any extremity should occur.
You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch
or call 1-800-FDA-1088.